Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FMG4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,927
Award facts
- Contract value 100% obligated
- $19,926.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Wegovy 1 mg/0.5 mL pen injectors in 0.5 mL quantities. The contract, valued at $19,926.95 with a firm fixed price structure, was competitively awarded without a set-aside designation and carries an ultimate completion date of November 10, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which enables the contractor to supply an extensive range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen's federal contract portfolio demonstrates its critical role in supplying specialized pharmaceuticals to military and veteran healthcare systems. The company's delivery orders under the IDC vehicle cover diverse therapeutic categories including diabetes medications, neurological treatments, pain management pharmaceuticals, and vaccines. The DLA Troop Support Medical contract vehicle supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible procurement mechanisms. This award for Wegovy, a GLP-1 receptor agonist indicated for weight management, reflects the expanding scope of pharmaceutical products being procured through federal supply channels for military personnel healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FMG4L?
SPE2DR26FMG4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FMG4L worth?
The government has obligated $19,927 on SPE2DR26FMG4L.
Is contract SPE2DR26FMG4L an order under another contract?
Yes. SPE2DR26FMG4L is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMG4L competed?
The extent of competition for SPE2DR26FMG4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award